Clinical Trial Update: A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test

View source ↗

Summary

Roche is sponsoring a global cancer registry enrolling participants with solid tumors who will be profiled using a next-generation sequencing test. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Solid Tumours | Status: RECRUITING